Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. / Moldovan, Mihai; Pinchenko, Volodymyr; Dmytriyeva, Oksana; Pankratova, Stanislava; Fugleholm, Kåre; Klingelhöfer, Jörg; Bock, Elisabeth; Berezin, Vladimir; Krarup, Christian; Kiryushko, Darya.

I: Molecular Medicine, Bind 19, 2013, s. 43-53.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Moldovan, M, Pinchenko, V, Dmytriyeva, O, Pankratova, S, Fugleholm, K, Klingelhöfer, J, Bock, E, Berezin, V, Krarup, C & Kiryushko, D 2013, 'Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice', Molecular Medicine, bind 19, s. 43-53. https://doi.org/10.2119/molmed.2012.00248

APA

Moldovan, M., Pinchenko, V., Dmytriyeva, O., Pankratova, S., Fugleholm, K., Klingelhöfer, J., ... Kiryushko, D. (2013). Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. Molecular Medicine, 19, 43-53. https://doi.org/10.2119/molmed.2012.00248

Vancouver

Moldovan M, Pinchenko V, Dmytriyeva O, Pankratova S, Fugleholm K, Klingelhöfer J o.a. Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. Molecular Medicine. 2013;19:43-53. https://doi.org/10.2119/molmed.2012.00248

Author

Moldovan, Mihai ; Pinchenko, Volodymyr ; Dmytriyeva, Oksana ; Pankratova, Stanislava ; Fugleholm, Kåre ; Klingelhöfer, Jörg ; Bock, Elisabeth ; Berezin, Vladimir ; Krarup, Christian ; Kiryushko, Darya. / Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. I: Molecular Medicine. 2013 ; Bind 19. s. 43-53.

Bibtex

@article{9b7de4205b574b3788279b54f59138d3,
title = "Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice",
abstract = "We recently found that S100A4, a member of the multifunctional S100 protein family, protects neurons in the injured brain and identified two sequence motifs in S100A4 mediating its neurotrophic effect. Synthetic peptides encompassing these motifs stimulated neuritogenesis and survival in vitro and mimicked the S100A4-induced neuroprotection in brain trauma. Here, we investigated a possible function of S100A4 and its mimetics in the pathologies of the peripheral nervous system (PNS). We found that S100A4 was expressed in the injured PNS and that its peptide mimetic (H3) affected the regeneration and survival of myelinated axons. H3 accelerated electrophysiological, behavioral and morphological recovery after sciatic nerve crush while transiently delaying regeneration after sciatic nerve transection and repair. On the basis of the finding that both S100A4 and H3 increased neurite branching in vitro, these effects were attributed to the modulatory effect of H3 on initial axonal sprouting. In contrast to the modest effect of H3 on the time course of regeneration, H3 had a long-term neuroprotective effect in the myelin protein P0 null mice, a model of dysmyelinating neuropathy (Charcot-Marie-Tooth type 1 disease), where the peptide attenuated the deterioration of nerve conduction, demyelination and axonal loss. From these results, S100A4 mimetics emerge as a possible means to enhance axonal sprouting and survival, especially in the context of demyelinating neuropathies with secondary axonal loss, such as Charcot-Marie-Tooth type 1 disease. Moreover, our data suggest that S100A4 is a neuroprotectant in PNS and that other S100 proteins, sharing high homology in the H3 motif, may have important functions in PNS pathologies.",
author = "Mihai Moldovan and Volodymyr Pinchenko and Oksana Dmytriyeva and Stanislava Pankratova and K{\aa}re Fugleholm and J{\"o}rg Klingelh{\"o}fer and Elisabeth Bock and Vladimir Berezin and Christian Krarup and Darya Kiryushko",
year = "2013",
doi = "10.2119/molmed.2012.00248",
language = "English",
volume = "19",
pages = "43--53",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "BioMed Central",

}

RIS

TY - JOUR

T1 - Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice

AU - Moldovan, Mihai

AU - Pinchenko, Volodymyr

AU - Dmytriyeva, Oksana

AU - Pankratova, Stanislava

AU - Fugleholm, Kåre

AU - Klingelhöfer, Jörg

AU - Bock, Elisabeth

AU - Berezin, Vladimir

AU - Krarup, Christian

AU - Kiryushko, Darya

PY - 2013

Y1 - 2013

N2 - We recently found that S100A4, a member of the multifunctional S100 protein family, protects neurons in the injured brain and identified two sequence motifs in S100A4 mediating its neurotrophic effect. Synthetic peptides encompassing these motifs stimulated neuritogenesis and survival in vitro and mimicked the S100A4-induced neuroprotection in brain trauma. Here, we investigated a possible function of S100A4 and its mimetics in the pathologies of the peripheral nervous system (PNS). We found that S100A4 was expressed in the injured PNS and that its peptide mimetic (H3) affected the regeneration and survival of myelinated axons. H3 accelerated electrophysiological, behavioral and morphological recovery after sciatic nerve crush while transiently delaying regeneration after sciatic nerve transection and repair. On the basis of the finding that both S100A4 and H3 increased neurite branching in vitro, these effects were attributed to the modulatory effect of H3 on initial axonal sprouting. In contrast to the modest effect of H3 on the time course of regeneration, H3 had a long-term neuroprotective effect in the myelin protein P0 null mice, a model of dysmyelinating neuropathy (Charcot-Marie-Tooth type 1 disease), where the peptide attenuated the deterioration of nerve conduction, demyelination and axonal loss. From these results, S100A4 mimetics emerge as a possible means to enhance axonal sprouting and survival, especially in the context of demyelinating neuropathies with secondary axonal loss, such as Charcot-Marie-Tooth type 1 disease. Moreover, our data suggest that S100A4 is a neuroprotectant in PNS and that other S100 proteins, sharing high homology in the H3 motif, may have important functions in PNS pathologies.

AB - We recently found that S100A4, a member of the multifunctional S100 protein family, protects neurons in the injured brain and identified two sequence motifs in S100A4 mediating its neurotrophic effect. Synthetic peptides encompassing these motifs stimulated neuritogenesis and survival in vitro and mimicked the S100A4-induced neuroprotection in brain trauma. Here, we investigated a possible function of S100A4 and its mimetics in the pathologies of the peripheral nervous system (PNS). We found that S100A4 was expressed in the injured PNS and that its peptide mimetic (H3) affected the regeneration and survival of myelinated axons. H3 accelerated electrophysiological, behavioral and morphological recovery after sciatic nerve crush while transiently delaying regeneration after sciatic nerve transection and repair. On the basis of the finding that both S100A4 and H3 increased neurite branching in vitro, these effects were attributed to the modulatory effect of H3 on initial axonal sprouting. In contrast to the modest effect of H3 on the time course of regeneration, H3 had a long-term neuroprotective effect in the myelin protein P0 null mice, a model of dysmyelinating neuropathy (Charcot-Marie-Tooth type 1 disease), where the peptide attenuated the deterioration of nerve conduction, demyelination and axonal loss. From these results, S100A4 mimetics emerge as a possible means to enhance axonal sprouting and survival, especially in the context of demyelinating neuropathies with secondary axonal loss, such as Charcot-Marie-Tooth type 1 disease. Moreover, our data suggest that S100A4 is a neuroprotectant in PNS and that other S100 proteins, sharing high homology in the H3 motif, may have important functions in PNS pathologies.

U2 - 10.2119/molmed.2012.00248

DO - 10.2119/molmed.2012.00248

M3 - Journal article

VL - 19

SP - 43

EP - 53

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

ER -

ID: 61729717